An unusual recurrent high-grade glioneuronal tumor with MAP2K1 mutation and CDKN2A/B homozygous deletion.
Barry CheaneyStephen BowdenKatie KrauseEmily A SloanArie PerryDavid A SolomonSeunggu Jude HanMatthew D WoodPublished in: Acta neuropathologica communications (2019)
Keyphrases